Nataline Sarkisyan, 17, died last week after suffering complications following a bone marrow transplant. Cigna had refused to cover a liver transplant the girl's doctors had requested, dubbing it "experimental," only to reconsider at the last minute when the girl's parents had already decided to take her off life support.[more]
After taking a beating in the press and on the Web, the Philadelphia-based insurance giant distributed a letter to the press Monday defending their decision.
In a letter cowritten by Cigna President David Cardani and Chief Medical Officer Dr. Jeffrey Kang, the company said they doubted the efficacy of the transplant procedure in Sarkisyan's case.
"In this case, rather than going through our standard method of appeal, we went directly to not one, but two independent experts in the field who agreed that the procedure in question, given the patient's particular circumstances, would not have been an effective or appropriate treatment," they wrote, evaluating her case on "evidence-based guidelines published by independent physician and medical organizations, as well as expert scientific journals."
Sarkisyan's family say they will sue the insurer. They allege Cigna twice took her off the transplant list and "purposely" waited until she was near death to approve the transplant because the firm didn't want to bear the costs of the procedure or rehabilitation following the operation.
Thursday, December 27, 2007
The World's Greatest Healthcare System -- Because We Have The World's Greatest Health Insurers
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment